|Bid||70.02 x 800|
|Ask||72.31 x 800|
|Day's range||71.12 - 73.39|
|52-week range||50.50 - 100.00|
|Beta (5Y monthly)||N/A|
|PE ratio (TTM)||254.37|
|Earnings date||07 Mar 2022 - 11 Mar 2022|
|Forward dividend & yield||N/A (N/A)|
|1y target est||111.67|
This is an awfully scary time to be a growth stock investor. It seems like hardly a day goes by when the most popular stocks don't move by 5% or more. Those moves have been to the downside so often that some of the best-performing stocks of 2020 and 2021 have lost over half their value.
Inari Medical (NARI) continues to benefit from its commitment toward understanding the venous system. However, dependency on the wide adoption of products is a woe.
What are the early trends we should look for to identify a stock that could multiply in value over the long term...